Ignite Creation Date:
2025-12-24 @ 6:47 PM
Ignite Modification Date:
2026-01-05 @ 6:15 PM
Study NCT ID:
NCT00346957
Status:
COMPLETED
Last Update Posted:
2012-03-06
First Post:
2006-06-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase II Study of Anecortave Acetate for the Treatment of Exudative Age-Related Macular Degeneration
Sponsor:
Alcon Research
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
1999-04
Start Date Type:
None
Primary Completion Date:
2003-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2003-04
Completion Date Type:
ACTUAL
First Submit Date:
2006-06-28
First Submit QC Date:
None
Study First Post Date:
2006-07-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-03-03
Last Update Post Date:
2012-03-06
Last Update Post Date Type:
ESTIMATED